CytoCore, Inc. (CYOE) - Financial and Strategic SWOT Analysis Review

Date: July 2, 2014
Pages: 44
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: CFF0429B9C1EN
Leaflet:

Download PDF Leaflet

CytoCore, Inc. (CYOE) - Financial and Strategic SWOT Analysis Review
CytoCore, Inc. (CYOE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

CytoCore, Inc. (CCI), formerly Molecular Diagnostics, Inc., is a biotechnology company. It undertakes the design, development and commercialization of cost-effective screening systems for the early detection of cancer. The major product developed by the company is CytoCore Solutions System, a simple and cost-effective method to screen women for endometrial cancer. It consists of four distinct components, namely, the SoftPAP cervical cell collector, the AIPS microscope platform, drug delivery system for treating cervical lesions, and a protein-based biochemical cocktails and slide-based tests.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

CytoCore, Inc. - Key Facts
CytoCore, Inc. - Key Employees
CytoCore, Inc. - Key Employee Biographies
CytoCore, Inc. - Major Products and Services
CytoCore, Inc. - Medical Equipment Pipeline Products Data
CytoCore, Inc. Pipeline Products by Equipment Type
CytoCore, Inc. Pipeline Products by Development Stage
CytoCore, Inc. - History
CytoCore, Inc. - Company Statement
CytoCore, Inc. - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

CytoCore, Inc. - Business Description
CytoCore, Inc. - Corporate Strategy
CytoCore, Inc. - SWOT Analysis
SWOT Analysis - Overview
CytoCore, Inc. - Strengths
Strength - Strategic Agreements
Strength - Proprietary CytoCore Solutions
Strength - Intellectual Property Portfolio
CytoCore, Inc. - Weaknesses
Weakness - History of Operating Losses
CytoCore, Inc. - Opportunities
Opportunity - Diagnostic Focus
Opportunity - Expansion in Emerging Markets
Opportunity - Acquisition of Medite
CytoCore, Inc. - Threats
Threat - Intense Competition
Threat - Cost Containment Pressures
Threat - Stringent Government Regulations
CytoCore, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

CytoCore, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
CytoCore, Inc., Medical Equipment, Deals By Type, 2008 to YTD 2014
CytoCore, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
CytoCore, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
CytoCore, Inc., Recent Deals Summary

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

CytoCore, Inc., Key Facts
CytoCore, Inc., Key Employees
CytoCore, Inc., Key Employee Biographies
CytoCore, Inc., Major Products and Services
CytoCore, Inc. Number of Pipeline Products by Equipment Type
CytoCore, Inc. Pipeline Products by Equipment Type
CytoCore, Inc. Number of Pipeline Products by Development Stage
CytoCore, Inc. Pipeline Products by Development Stage
CytoCore, Inc., History
CytoCore, Inc., Key Competitors
CytoCore, Inc., Ratios based on current share price
CytoCore, Inc., Annual Ratios
CytoCore, Inc., Interim Ratios
CytoCore, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
CytoCore, Inc., Medical Equipment, Deals By Type, 2008 to YTD 2014
CytoCore, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
CytoCore, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
CytoCore, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

CytoCore, Inc. Pipeline Products by Equipment Type
CytoCore, Inc. Pipeline Products by Development Stage
CytoCore, Inc., Performance Chart (2009 - 2013)
CytoCore, Inc., Ratio Charts
CytoCore, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
CytoCore, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014
CytoCore, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
CytoCore, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Skip to top


Ask Your Question

CytoCore, Inc. (CYOE) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: